Literature DB >> 11923431

Metabotropic glutamate receptor 5 upregulation in A-fibers after spinal nerve injury: 2-methyl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia.

Lindsey J Hudson1, Stuart Bevan, Kara McNair, Clive Gentry, Alyson Fox, Rainer Kuhn, Janet Winter.   

Abstract

Metabotropic glutamate receptor 5 (mGluR5) protein increased after sciatic nerve section in ipsilateral L4 and L5 DRG neuronal profiles, with most of the increase occurring in myelinated A-fiber somata. mGluR5 also increased in lamina II of the ipsilateral spinal cord and the proximal sciatic nerve stump in this model. After L5 spinal nerve ligation, mGluR5 immunoreactivity increased dramatically not only in damaged L5 but also in the neighboring undamaged L4. Interestingly, after partial sciatic nerve section, mGluR5 expression did not change in either L4 or L5 DRG neuronal profiles. Both spinal nerve ligation and sciatic nerve partial section produced significant mechanical and thermal hyperalgesia and tactile allodynia. After partial sciatic nerve section, the mGluR5-specific antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) had no effect on any of these behaviors. However, after L5 spinal nerve ligation, although MPEP failed to alter the induced tactile allodynia or mechanical hyperalgesia, it dose dependently reversed the developed thermal hyperalgesia. Therefore, reversal of thermal hyperalgesia by MPEP correlates with increased mGluR5 in lumbar DRG A-fiber somata after nerve injury. Furthermore, A-fibers in the uninjured L4 DRG after L5 spinal nerve ligation that have increased mGluR5 are the same A-fibers that newly express vanilloid receptor 1 after such injury. Together, these results suggest that, after L5 spinal nerve injury, mGluR5 expression on A-fibers is essential to the development of thermal hyperalgesia. After partial nerve section, however, it is unlikely that thermal responses are mediated through mGluR5 because no such increase in mGluR5 is detected in this model and MPEP is ineffective.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923431      PMCID: PMC6758316          DOI: 20026229

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

Review 1.  Second messengers, the substantia gelatinosa and injury-induced persistent pain.

Authors:  K R Petersen-Zeitz; A I Basbaum
Journal:  Pain       Date:  1999-08       Impact factor: 6.961

Review 2.  Spinal nerve ligation: what to blame for the pain and why.

Authors:  M S Gold
Journal:  Pain       Date:  2000-02       Impact factor: 6.961

3.  The capsaicin receptor: a heat-activated ion channel in the pain pathway.

Authors:  M J Caterina; M A Schumacher; M Tominaga; T A Rosen; J D Levine; D Julius
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

4.  Cross-excitation in dorsal root ganglia of nerve-injured and intact rats.

Authors:  M Devor; P D Wall
Journal:  J Neurophysiol       Date:  1990-12       Impact factor: 2.714

5.  Sprouting of A beta fibers into lamina II of the rat dorsal horn in peripheral neuropathy.

Authors:  H A Lekan; S M Carlton; R E Coggeshall
Journal:  Neurosci Lett       Date:  1996-04-26       Impact factor: 3.046

6.  Comparison of sympathetic sprouting in sensory ganglia in three animal models of neuropathic pain.

Authors:  B H Lee; Y W Yoon; K Chung; J M Chung
Journal:  Exp Brain Res       Date:  1998-06       Impact factor: 1.972

Review 7.  Sensitization of pain pathways in the spinal cord: cellular mechanisms.

Authors:  G Baranauskas; A Nistri
Journal:  Prog Neurobiol       Date:  1998-02       Impact factor: 11.685

8.  Effects of the capsaicin analogue resiniferatoxin on spinal nociceptive mechanisms in the rat: behavioral, electrophysiological and in situ hybridization studies.

Authors:  X J Xu; T Farkas-Szallasi; J M Lundberg; T Hökfelt; Z Wiesenfeld-Hallin; A Szallasi
Journal:  Brain Res       Date:  1997-03-28       Impact factor: 3.252

9.  2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.

Authors:  F Gasparini; K Lingenhöhl; N Stoehr; P J Flor; M Heinrich; I Vranesic; M Biollaz; H Allgeier; R Heckendorn; S Urwyler; M A Varney; E C Johnson; S D Hess; S P Rao; A I Sacaan; E M Santori; G Veliçelebi; R Kuhn
Journal:  Neuropharmacology       Date:  1999-10       Impact factor: 5.250

10.  A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats.

Authors:  Y Shir; Z Seltzer
Journal:  Neurosci Lett       Date:  1990-07-17       Impact factor: 3.046

View more
  29 in total

Review 1.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

2.  Involvement of metabotropic glutamate receptor 5 in pudendal inhibition of nociceptive bladder activity in cats.

Authors:  Jeffrey A Larson; P Dafe Ogagan; Guoqing Chen; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai
Journal:  J Physiol       Date:  2011-10-17       Impact factor: 5.182

Review 3.  Glutamate receptor phosphorylation and trafficking in pain plasticity in spinal cord dorsal horn.

Authors:  Xue Jun Liu; Michael W Salter
Journal:  Eur J Neurosci       Date:  2010-07-11       Impact factor: 3.386

4.  Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing.

Authors:  E Palazzos; V de Novellis; I Marabese; F Rossi; S Maione
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

5.  Peripheral metabotropic glutamate receptor subtype 5 contributes to inflammation-induced hypersensitivity of the rat temporomandibular joint.

Authors:  Bo Li; Li Lu; Xuexin Tan; Ming Zhong; Yan Guo; Xin Yi
Journal:  J Mol Neurosci       Date:  2013-06-27       Impact factor: 3.444

6.  Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist.

Authors:  O El-Kouhen; S G Lehto; J B Pan; R Chang; S J Baker; C Zhong; P R Hollingsworth; J P Mikusa; E A Cronin; K L Chu; S P McGaraughty; M E Uchic; L N Miller; N M Rodell; M Patel; P Bhatia; M Mezler; T Kolasa; G Z Zheng; G B Fox; A O Stewart; M W Decker; R B Moreland; J D Brioni; P Honore
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

7.  Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia.

Authors:  Wei Guo; Feng Wei; Shiping Zou; Meredith T Robbins; Shinichi Sugiyo; Tetsuya Ikeda; Jian-Cheng Tu; Paul F Worley; Ronald Dubner; Ke Ren
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

8.  Simulated whiplash modulates expression of the glutamatergic system in the spinal cord suggesting spinal plasticity is associated with painful dynamic cervical facet loading.

Authors:  Ling Dong; Beth A Winkelstein
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

9.  Spinal Metabotropic Glutamate Receptors (mGluRs) are Involved in the Melittin-induced Nociception in Rats.

Authors:  Chul Hyun Cho; Hong Kee Shin
Journal:  Korean J Physiol Pharmacol       Date:  2008-10-31       Impact factor: 2.016

Review 10.  Cancer-induced oxidative stress and pain.

Authors:  Mina G Nashed; Matthew D Balenko; Gurmit Singh
Journal:  Curr Pain Headache Rep       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.